Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: A comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation

European Heart Journal Cardiovascular Imaging

Volumn 16, Issue 10, 2015, Pages 1101-1111

  Tada, Takeshi ^a   Kadota, Kazushige ^a   Hosogi, Shingo ^b   Miyake, Koshi ^a   Ohya, Masanobu ^a   Amano, Hideo ^a   Izawa, Yu ^a   Kanazawa, Takenori ^a   Kubo, Shunsuke ^a   Ichinohe, Tahei ^a   Hyoudou, Yusuke ^a   Hayakawa, Yuki ^a   Sabbah, Mahmoud Mohamed Hassan ^c   Otsuru, Suguru ^a   Hasegawa, Daiji ^a   Habara, Seiji ^a   Tanaka, Hiroyuki ^a   Fuku, Yasushi ^a   Katoh, Harumi ^a   Goto, Tsuyoshi ^a   Mitsudo, Kazuaki ^a   more..

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

^b Kochi Health Sciences Center   (Japan)

^c Suez Canal University Faculty of Medicine   (Egypt)

Author keywords

In stent restenosis lesion; Optical coherence tomography; Paclitaxel coated balloon

Indexed keywords

PACLITAXEL;

AGED; ARTICLE; BALLOON DILATATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RECURRENT DISEASE; TISSUE STRUCTURE; ADVERSE EFFECTS; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; CORONARY BLOOD VESSEL; CORONARY RESTENOSIS; DEVICES; PATHOLOGY; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; RECURRENCE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; STENTS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84954055796     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jev031     Document Type: Article

References (12)

1. Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009;158:284-93.
2. Tada T, Kadota K, Hosogi S, Miyake K, Amano H, Nakamura M et al. Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty. Eur Heart J Cardiovasc Imaging 2014;15:307-15.
3. Habara M, Nasu K, Terashima M, Kaneda H, Yokota D, Ko E et al. Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: an optical coherence tomography study. Circ Cardiovasc Interv 2011;4:232-8.
4. Habara M, Terashima M, Nasu K, Kaneda H, Yokota D, Ito T et al. Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: an optical coherence tomography study. Eur Heart J Cardiovasc Imaging 2013;14:276-84.
5. Nagoshi R, Shinke T, Otake H, Shite J, Matsumoto D, Kawamori H et al. Qualitative and quantitative assessment of stent restenosis by optical coherence tomographycomparison between drug-eluting and bare-metal stents. Circ J 2013;77:652-60.
6. Nagai H, Ishibashi-Ueda H, Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis. Catheter Cardiovasc Interv 2010;75:961-3.
7. Nakano M, Vorpahl M, Otsuka F, Taniwaki M, Yazdani SK, Finn AV et al. Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging. JACC Cardiovasc Imaging 2012;5:71-82.
8. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004;109:701-5.
9. Nakazawa G, Finn AV, Vorpahl M, Ladich ER, Kolodgie FD, Virmani R. Coronary responses and differential mechanisms of late stent thrombosis attributed to firstgeneration sirolimus- and paclitaxel-eluting stents. J Am Coll Cardiol 2011;57:390-8.
10. Habara S, Iwabuchi M, Inoue N, Nakamura S, Asano R, Nanto S et al. Amulticenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Am Heart J 2013;166:527-33.
11. Whan Lee C, Kim SH, Suh J, Park DW, Lee SH, Kim YH et al. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents. Catheter Cardiovasc Interv 2008;71:594-8.
12. Steinberg DH, Gaglia MA Jr, Pinto Slottow TL, Roy P, Bonello L, De Labriolle A et al. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol 2009;103:491-5.